Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 43063-482

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 43063-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 01

FDA Label Image

3a53f18e Af9b 4932 8300 B3521e87528d 02

FDA Label Image

Image (43063482)

Image (43063482)
This is a pharmaceutical label for LISINOPRIL/HCTZ tablets containing 10mg/12.5mg strength. The label includes dosage and storage information, expiration date, lot number, and reorder number. The warning advises to keep it out of the reach of children. There is a disclaimer to consult a doctor for medical advice about side effects and also mentions the possibility of reporting side effects to the FDA. The label also includes a caution that if pregnancy is detected, the medication should be discontinued.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.